financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Shares Of Caesars Entertainment, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Shares Of Caesars Entertainment, Inc.
May 1, 2024 5:59 AM

08:30 AM EDT, 05/01/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month price target by $5 to $37, based on 5.4x our 2024 EBITDA estimate and below the company's 1-year average forward EV/EBITDA multiple of 8.7x, reflecting our view that CZR is overleveraged with an EBIT/Interest Expense ratio of just 1.1x during a strong economic year in the U.S. We lower our 2024 EPS estimate by $0.60 to $0.40 and 2025 EPS estimate by $0.50 to $0.75. CZR posts normalized Q1 EPS of ($0.44) vs. $0.14, $0.38 below consensus estimates on revenues of $2.74B vs. $2.83B and $88M below estimates. By segment, Las Vegas revenues declined 4.5% Y/Y, Regional declined 1.7%, and Caesars Digital increased 18.5%. Debt remains our biggest concern as the company has repaid almost none of its debt load and refinanced a large portion in Q1. We wouldn't be surprised to see the company sell off some of its assets over the next year to pay down some of its debt. That being said, valuation has compressed significantly and we believe shares trade near fair value.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Lowers Opinion On Health Care To Underweight From Marketweight
Research Alert: CFRA Lowers Opinion On Health Care To Underweight From Marketweight
Jun 13, 2025
12:50 PM EDT, 06/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We continue to see elevated policy uncertainties ahead in health care with the on-going Section 232 investigation to assess the impact of pharmaceuticals and API imports on national security. The...
Research Alert: CFRA Lowers Opinion On Shares Of Shell To Sell From Hold
Research Alert: CFRA Lowers Opinion On Shares Of Shell To Sell From Hold
Jun 13, 2025
03:40 AM EDT, 06/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target price for Shell at USD59 based on 2025 P/E of 9.2x, which reflects 0.5 standard deviation below its 10-year average of 11.6x. Our EPS forecasts...
Research Alert: CFRA Raises Opinion On The Energy Sector To Marketweight From Underweight
Research Alert: CFRA Raises Opinion On The Energy Sector To Marketweight From Underweight
Jun 13, 2025
09:20 AM EDT, 06/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: In light of the Israeli attack on Iran's nuclear facilities, we recommend upgrading the investment outlook for the Energy Sector. If the military action expands to include Iran's oil facilities,...
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Jun 13, 2025
04:35 AM EDT, 06/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We revised our target price to USD81 (up from USD64), which implies 19.6x our 2025 EPADS. This is at a discount to its historical forward P/E average of 30x-32x, justified...
Copyright 2023-2026 - www.financetom.com All Rights Reserved